The anti‐aging Klotho protects glioblastoma macrophages from radiotherapy‐induced inflammation and predicts immunotherapy response
International Journal of Cancer · 2025
DOI: 10.1002/ijc.70038 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Andrea Galluzzo und 19 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Immunotherapy of Brain Tumors, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. Hauptthemen laut MEDLINE: Glioblastoma, Glucuronidase, Immunotherapy, Macrophages. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Ministry of Health, Ministero della Salute.
Abstract (Originalsprache)
Immunosuppressive myeloid cells, such as microglia and macrophages, play a key role in mediating resistance to immunotherapy in glioblastoma patients. Bulk RNA sequencing analysis revealed elevated expression of Klotho ( Kl ) in gliomas derived from irradiated glioma‐bearing mice. Klotho , which encodes an anti‐aging protein, was found to be upregulated in glioma‐associated microglia/macrophages (GAMs) exhibiting an M1 pro‐inflammatory phenotype. This upregulation appeared to enhance the antitumor efficacy of a combination of radiotherapy and dendritic cell (DC) immunotherapy. Furthermore, transcript levels of KL in tumor specimens and corresponding serum levels in glioblastoma patients undergoing DC immunotherapy were correlated with favorable prognostic outcomes and improved treatment responses. Given its expression in human M1‐like GAMs, serum KL levels can offer valuable insights into the immune microenvironment and hold clinical significance as a peripheral biomarker. These findings highlight the pivotal role of Klotho as a prognostic biomarker for predicting responses to immunotherapy, with potential applications for monitoring tumor progression or regression through changes in serum levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Immunotherapy of Brain Tumors, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
- Unit of Neuroncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
- Unit of Neuro-Radiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
- Data Science Center, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
- Unit of Neuro-Pathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
- Laboratory of Neuro-Oncology Genetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
ORCID-Profile: Marco Schiariti
Förderung
- Italian Ministry of Health
- Ministero della Salute
Zitieren
APA
Galluzzo, A., Maffezzini, M., Fumagalli, M. L., Sambruni, I., Musio, S., Patanè, M., Paterra, R., Salvi, E., Facciolla, M., Milani, M., Schiariti, M., Mattei, L., Rossi, A., Eoli, M., Poliani, L., Silvani, A., Pollo, B., Fariselli, L., Di Ianni, N., & Pellegatta, S. (2025). The anti‐aging Klotho protects glioblastoma macrophages from radiotherapy‐induced inflammation and predicts immunotherapy response. International Journal of Cancer. https://doi.org/10.1002/ijc.70038
Vancouver
Galluzzo A, Maffezzini M, Fumagalli ML, Sambruni I, Musio S, Patanè M, et al. The anti‐aging Klotho protects glioblastoma macrophages from radiotherapy‐induced inflammation and predicts immunotherapy response. International Journal of Cancer. 2025. doi:10.1002/ijc.70038
BibTeX
@article{Galluzzo2025,
author = {Galluzzo, Andrea and Maffezzini, Martina and Fumagalli, Maria Luisa and Sambruni, Irene and Musio, Silvia and Patanè, Monica and Paterra, Rosina and Salvi, Erika and Facciolla, Manuel and Milani, Micaela and Schiariti, Marco and Mattei, Luca and Rossi, Alessandra and Eoli, Marica and Poliani, Luigi and Silvani, Antonio and Pollo, Bianca and Fariselli, Laura and Di Ianni, Natalia and Pellegatta, Serena},
title = {The anti‐aging Klotho protects glioblastoma macrophages from radiotherapy‐induced inflammation and predicts immunotherapy response},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.70038}
}
EUVIMED